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Abstract
Most human exposures to ionising radiation are partial body exposures. However, to date only limited tools are available for
rapid and accurate estimation of the dose distribution and the extent of the body spared from the exposure. These
parameters are of great importance for emergency triage and clinical management of exposed individuals. Here,
measurements of c-H2AX immunofluorescence by microscopy and flow cytometry were compared as rapid biodosimetric
tools for whole and partial body exposures. Ex vivo uniformly X-irradiated blood lymphocytes from one donor were used to
generate a universal biexponential calibration function for c-H2AX foci/intensity yields per unit dose for time points up to
96 hours post exposure. Foci – but not intensity – levels remained significantly above background for 96 hours for doses of
0.5 Gy or more. Foci-based dose estimates for ex vivo X-irradiated blood samples from 13 volunteers were in excellent
agreement with the actual dose delivered to the targeted samples. Flow cytometric dose estimates for X-irradiated blood
samples from 8 volunteers were in excellent agreement with the actual dose delivered at 1 hour post exposure but less so
at 24 hours post exposure. In partial body exposures, simulated by mixing ex vivo irradiated and unirradiated lymphocytes,
foci/intensity distributions were significantly over-dispersed compared to uniformly irradiated lymphocytes. For both
methods and in all cases the estimated fraction of irradiated lymphocytes and dose to that fraction, calculated using the
zero contaminated Poisson test and c-H2AX calibration function, were in good agreement with the actual mixing ratios and
doses delivered to the samples. In conclusion, c-H2AX analysis of irradiated lymphocytes enables rapid and accurate
assessment of whole body doses while dispersion analysis of foci or intensity distributions helps determine partial body
doses and the irradiated fraction size in cases of partial body exposures.
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Introduction
Dose assessments based on well established cytogenetic assays
and especially those utilising emerging techniques in the field of
biological dosimetry are mainly suited for whole body exposures to
ionising radiation [1]. However, most human radiation exposures
are partial body exposures, whether during planned medical
exposures or in the case of radiation accidents. Information about
the extent of ‘sparing’ of normal tissues during a high dose
exposure and accurate estimates of peak doses delivered to
localised regions of the body are of crucial importance for the
clinical management of radiation casualties [2]. To address this
need, analytical methods have been developed for the long-
established dicentric assay, the current ‘gold standard’ in biological
dosimetry, to identify partial body exposures and calculate the
irradiated fraction of the body and estimate peak doses to the
irradiated fraction [3]. In contrast, many of the emerging
biological dosimetry techniques, which focus on quick dose
assessments to facilitate rapid triage, have not been tested as
rigorously in cases of partial body exposure settings.
The phosphorylated histone H2A variant c-H2AX and p53
binding protein 53BP1 are established immunocytochemical
markers of ionising radiation-induced DNA double-strand breaks
(DSBs) [4,5] and are emerging biomarkers of radiation exposure
[6,7]. c-H2AX and 53BP1 foci form at the sites of DSBs and can
be visualised within minutes of exposure [8]. Their potential for
accurately estimating radiation dose has already been reported
following experimental human ex vivo [9–11], non-human primate
in vivo [12] and diagnostic [8] or therapeutic [13] human in vivo
exposure. These studies demonstrate excellent sensitivity down to
a few milligray, the ability of the c-H2AX assay to identify a recent
partial body exposure, and persistence of foci for several days after
high dose exposure.
As an alternative to scoring c-H2AX foci by immunofluores-
cence microscopy, c-H2AX can also be quantified by flow
cytometry [14,15]. Although both methods measure c-H2AX
levels using immunofluorescence assays, flow cytometry detects
total fluorescence intensity in each cell whilst microscopy allows
scoring of individual foci [7]. The main advantage of flow
cytometry is speed; where scoring foci by eye can be laborious
(although still far faster than dicentric scoring), flow cytometry
can rapidly analyse thousands of cells within minutes in an
unsupervised manner. Even automated foci scoring is signifi-
cantly slower, as multiple fields of view, optical planes at
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high spatial resolution, followed by the actual image analysis
procedures for foci scoring [16–18]. Although the analysis speed
differs between the two techniques, the sample processing and
immunostaining methods are largely similar and can be
completed in similar times.
For partial body exposures, estimating the fraction of the body
irradiated and dose to irradiated fraction require detailed analysis
of signal distributions and present a greater challenge in
interpreting results. For dicentric scoring, the distribution of
aberrations in the irradiated part of the lymphocyte pool plays a
key role [3]. A high abundance of both cells with multiple
dicentrics and cells with normal metaphases gives rise to an
overdispersed distribution of aberrations which is a hallmark of
partial body exposure. In contrast, whole body exposure to
sparsely ionising radiation results in the random induction of
aberrations in all cells and therefore follows a Poisson distribution
[19]. For densely ionising radiation however, even a whole body
exposure will result in a non-uniform dose distribution due to the
clustered energy deposition along the particle tracks [20], making
dose estimates modeled on Poisson distributions inappropriate.
Here we describe the use of c-H2AX and/or 53BP1
immunofluorescence microscopy and c-H2AX flow cytometry as
quantitative biomarkers for whole and partial body exposure to
ionising radiation.
Results
c-H2AX and 53BP1 foci induction is linear and loss
follows a bi-exponential decay that can be approximated
with one universal calibration function
In ex vivo irradiated human lymphocytes, c-H2AX and 53BP1
foci colocalized (Fig. 1A) and were linearly induced by acute X-ray
doses of 0.5 and 1 Gy between 1–4 hours post exposure (Fig. 1B)
and 0.5, 1 and 4 Gy between 24–96 hours post exposure (Fig. 1C).
Mean c-H2AX and 53BP1 foci counts per cell were very similar
for all samples except those with the highest levels of foci, i.e. 1, 2
and 4 hours post 4 Gy exposure. At 96 hours, the mean foci level
for 0.5 Gy-irradiated lymphocytes was significantly increased
against controls (p=0.015, t test).
Similar time courses of c-H2AX and 53BP1 foci loss over a
96 hour period after exposure to X-rays followed a bi-exponential
decay with a fast and a slow component for all doses (Fig. 1D).
Notably, the T1/2 Fast and T1/2 Slow half-lives were very similar at
all three doses, suggesting foci loss and therefore DSB repair is
independent of the X-ray dose received. With this information it
was decided a single decay could be used to describe c-H2AX loss
over 96 hours and was accomplished as follows: Mean foci yields
per gray, obtained by linear regression for each time point for c-
H2AX, were used to generate a dose-normalised biexponential c-
H2AX decay curve (Fig. 1E) which followed the function
y=11.92*exp(20.3495*x)+3.552*exp(20.01843*x), where y=
foci yield per gray and x=time in hours. Assuming dose is
proportional to foci yield, dose=foci scored/y at x hours post
exposure. A Pearson’s chi-square test to determine the goodness of
fit of the bi-exponential decay to the linear regression coefficients
for the dose response curves gave a value of p=0.998.
To confirm the validity of the c-H2AX foci calibration curve,
human lymphocytes from a group of healthy donors were
irradiated ex vivo with 0.5 Gy and 4 Gy and analysed at 1 and
24 hours post exposure, respectively. For foci scoring of 13 donors
(Fig. 1F), the dose estimates for 0.5 Gy 1 hour samples varied
between 0.43–0.56 Gy with a mean of 0.51 Gy. For 4 Gy 24 hour
samples dose estimates were between 2.9–4.7 Gy with a mean of
3.6 Gy.
c-H2AX intensity increases linearly with dose and loss
follows a bi-exponential decay that can be approximated
by one universal calibration function
c-H2AX intensity, as measured by flow cytometry, increased
linearly with dose in lymphocytes exposed ex vivo to 0.5–8 Gy X-
rays (Fig. 2A). At 1–4 hours but not at later time points, mean
intensity per cell for 0.5 Gy irradiated lymphocytes was signifi-
cantly increased compared to controls (p=0.0184, t test). The
lowest detectable dose increased to 4 Gy at 24 hours (p=0.0481).
In contrast to c-H2AX, 53BP1 intensity did not increase
significantly after irradiation (average intensities were (15.42 vs.
14.03 vs. 14.63, for 0, 0.5 and 4 Gy, respectively, at 1 hour post
exposure). As for foci loss the loss of c-H2AX intensity over
48 hours post-exposure followed a bi-exponential decay (Fig. 2B).
The T1/2 Fast and T1/2 Slow for intensity loss were however
considerably higher than those seen for foci loss, with the T1/2 Slow
component increasing slightly with dose. Linear regressions for c-
H2AX intensity yields per gray for each time point were used
to generate c-H2AX calibration data (Fig. 2C) which could
be described with the bi-exponential function y=8.593*
exp(20.3709*x)+1.136*exp(20.023235*x), where y=intensity
yield per gray and x=time in hours. As dose is proportional to
intensity yield, dose=intensity/y at x hours post exposure. A
Pearson’s chi-square test to determine the goodness of fit of the bi-
exponential decay to the linear regression coefficients for the dose
response curves produced a value of p=0.999. As with foci, the c-
H2AX intensity calibration curve was used to make dose estimates
in ex vivo irradiated human lymphocytes from a group of healthy
donors. For intensity measurements in 8 donors (Fig. 2D), the dose
estimates for 0.5 Gy 1 hour samples varied between 0.34–0.62 Gy
with a mean of 0.46 Gy. For 4 Gy 24 hour samples dose estimates
were between 1.78–3.59 Gy with a mean of 2.78 Gy.
Overdispersion analysis detects and quantifies simulated
partial body exposures in microscopic foci data sets
To determine whether microscopic foci analysis would be able
to detect and characterize partial body exposures, irradiated and
unirradiated lymphocytes were mixed in different ratios and the
irradiated fraction size and dose to the fraction estimated using the
contaminated Poisson method and c-H2AX calibration function
shown in Figure 1E.
Whilst different doses given to different fractions of the
lymphocyte pool can result in comparable mean foci numbers,
the distributions of these foci within the cell samples vary
considerably (Fig. 3A). Increasing the irradiated fraction size
linearly increased the mean number of foci per cell (Fig. 3B). At
1 hour, a dose of 0.5 Gy to 10% of the lymphocyte population
significantly increased mean foci per cell against controls
(p=0.0129, t test), whereas at 24 hours, a dose of 0.5 Gy to
50% of the lymphocyte population was required to significantly
increase the mean foci per cell against controls (p=0.0153, t test).
Using the calibration curve presented in Figure 1E, whole body
dose estimates were made based on the mean foci per cell scored
(Figure 3C). A dose of 4 Gy to 50% of the lymphocyte population
at 24 hours post exposure gave a mean value of 4.32 foci per cell.
Using: y=11.92*exp(20.3495*24)+3.552*exp(20.01843*24)=
2.2 foci per gray at 24 h, the calibration function delivered a
whole body dose estimate of 4.32/2.28 Gy=1.96 Gy.
The Poisson s values for every partially irradiated sample were
greater than 1.96, whereas wholly irradiated samples had s values
Dose Estimates Based on Gamma-H2AX
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therefore detectable, the next step in dose estimation was to
calculate the irradiated fraction size. Using the contaminated
Poisson method the irradiated fraction of lymphocytes was
estimated and compared to the actual irradiated fraction
(Fig. 3E). This method accurately predicted the irradiated fraction
for 0.5 Gy 1 hour, 0.5 Gy 24 hours and 4 Gy 24 hours (p=0.96,
p=0.988 and p=0.86 respectively, Pearson’s chi-square goodness
of fit test). For determining the dose to the irradiated fraction,
mean foci per cell in the irradiated fraction was calculated by:
fN=N(1/fP), where fN=mean foci per cell in the irradiated
fraction, N=mean foci per cell and fP the irradiated fraction size
calculated by contaminated Poisson.
For 4 Gy/24 hours/50% irradiated, the calculations for two
independent experiments were 4.1(1/0.45)=9.02 and 4.55(1/
0.42)=10.82, giving a mean value of 9.92 foci per cell. The dose
was then calculated using the calibration function in Figure 1E:
Dose to irradiated fraction=9.92/2.28 Gy=4.3 Gy. Using this
method, satisfactory dose estimations were made for all doses and
time points (Fig. 3F).
In addition to the contaminated Poisson algorithm, the Qdr
method, first proposed by Sasaki and Miyata [21] and more
recently suggested for cH2AX foci analysis by Redon et al. [22],
was applied to the data in Figure 3. However, these methods for
estimating irradiated fraction size and the mean foci per cell in
this fraction (termed FcH2AX and QcH2AX respectively [22])
were were generally found to be less accurate than the
contaminated Poisson approach. A Pearson’s chi-square goodness
of fit test gave p values for FcH2AX of p=0.75 (0.5 Gy 1 h),
p=1.1610
27 (0.5 Gy 24) and p=0.12 (4 Gy 24 h) and for
QcH2AX p=0.99, p=0.8 and p=0.69 for the same irradiation
conditions.
Figure 1. c-H2AX (open symbols) and 53BP1 (closed symbols) foci induction and loss after uniform exposure to X-rays, detected by
immunofluorescence microscopy. (A) Grey scale immunofluorescent images of 53BP1, c-H2AX and DAPI in irradiated lymphocytes and controls.
Each image is 8.467.6 mm in size. (B) Mean c-H2AX and 53BP1 foci observed between 1–4 hours post exposure. Linear regressions (solid lines for c-
H2AX, dashed for 53BP1) were fitted excluding the 4 Gy data points due to underscoring of foci. (C) Mean c-H2AX and 53BP1 foci observed between
24–96 hours post exposure. Linear regressions (solid for c-H2AX, dashed for 53BP1) are fitted to all data points. (D) c-H2AX foci loss over 96 hours.
Dashed lines represent bi-exponential fits for c-H2AX loss for each dose. T1/2 Fast and T1/2 Slow represent the individual half-lives of the two
exponentials. (E) c-H2AX foci yields per cell per gray between 1–96 hours calculated using linear regression coefficients of c-H2AX foci counts from
Figures 1B and 1C. The dashed line represents a bi-exponential fit for mean c-H2AX loss per unit dose and solid lines the upper and lower 95%
confidence limits. (F) Dose estimates in X-irradiated lymphocytes from 13 healthy donors. c-H2AX foci were scored and the dose estimated using the
calibration curve from Figure 1E. The dashed lines represent the average dose estimates based on all the donors.
doi:10.1371/journal.pone.0025113.g001
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partial body exposures in flow cytometric intensity sets
Flow cytometric c-H2AX intensity measurements in ex vivo
partially irradiated human lymphocytes and subsequent calcula-
tions were performed in a similar way as those for foci scoring. For
all partially 4 Gy-irradiated lymphocyte samples, two distinct cell
populations representing unirradiated and irradiated cells were
distinguishable in c-H2AX intensity histograms (Fig. 4A). At
1 hour post exposure, a dose of 4 Gy to 10% of the lymphocyte
population significantly increased the mean intensity per cell
above background (p=0.0063, t test). Using the calibration curve
presented in Figure 2C, whole body doses were estimated based on
the mean intensity per cell measured (Fig. 4B) as described
previously for foci data.
Poisson u values were at least 13 fold greater for partially 4 Gy-
irradiated samples than for uniformly irradiated samples (Fig. 4C),
indicating a much greater level of over-dispersion in partially
irradiated samples. The contaminated Poisson method was again
used to estimate the irradiated fraction of lymphocytes which is
compared to the actual irradiated fraction in Figure 4D. This
method accurately predicted the irradiated fraction size (p=0.999,
Pearson’s chi-square goodness of fit test). The dose to the
irradiated fraction was calculated as described previously for foci
data. Using this method dose estimations were made for all points
(Fig. 4E).
Discussion
Through immunofluorescence analysis, c-H2AX and 53BP1
have been shown to be accurate and easily quantifiable biomarkers
of ionising radiation exposure. Fluorescence microscopy certainly
possesses the required sensitivity [8], with sub-acute doses being
detectable days after exposure (Fig. 1). Flow cytometry on the
other hand, whilst capable of detecting increased c-H2AX levels
shortly after sub-acute irradiation, does not maintain the required
level of sensitivity beyond the first hours (Fig. 2) and appears to
show wider inter-individual variation [15,23]. Consequently, there
is only very limited scope for the application of flow cytometry as a
c-H2AX biodosimetry tool (outside of planned exposure scenarios
like radiotherapy). The problem appears to be intrinsic: while the
eye (or image analysis software) can pick out a focus clearly from
the non-specific background staining of a cell nucleus, flow
cytometry measures both background and the focus intensity,
resulting in increased ‘noise’ [7]. It has been reported that staining
for c-H2AX in unfixed cells increases sensitivity [23], but we have
not yet been able to successfully repeat this protocol. While
sensitivity is an issue, flow cytometry is a rapid and highly
automated technique capable of scoring tens of thousands of cells
within minutes. These qualities may be useful in the detection and
quantification of other radiation biomarkers [9,24].
The linear induction of c-H2AX foci levels or intensity and
53BP1 foci with dose observed here and elsewhere suggests that foci
and intensity yields per gray are constant; increasing the X-ray dose
linearly increases the number of electron tracks and ionisations that
produce DSBs in the cell. At 4 Gy 1–4 hours post exposure foci
counts for both c-H2AX and 53BP1 do not conform to linearity.
This ‘underscoring’ of foci at high doses early after exposure is likely
caused by the close proximity or even overlap of adjacent foci which
makes it impossible to distinguish each individual focus using
microscopy. For 53BP1, which relocalises to DSBs, intensity does
not increase after radiation exposure (see Results); foci numbers do
increase but deviate from linearity at doses above ,2 Gy at early
Figure 2. c-H2AX intensity induction and loss after uniform exposure to X-rays, detected by flow cytometry. (A) Mean c-H2AX intensity
observed between 1–48 hours post exposure. Linear regressions (lines) were fitted to all data points. (B) c-H2AX intensity loss over 48 hours post
exposure. Dashed lines represent bi-exponential fits for c-H2AX loss for each dose. T1/2 fast and T1/2 Slow represent the individual half-lives of the two
exponentials. (C) c-H2AX intensity yields per cell per gray between 1–48 hours calculated using linear regression coefficients of c-H2AX intensity
yields from Figure 2A. The dashed line represents a bi-exponential fit for mean c-H2AX loss per unit dose and solid lines the upper and lower 95%
confidence limits. (D) Dose estimates in X-irradiated lymphocytes from 8 healthy donors. c-H2AX intensity was measured and the dose estimated
using the calibration curve from Figure 2C.
doi:10.1371/journal.pone.0025113.g002
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accumulating at each break site, causing the dimming of individual
foci as fewer antibodies bind at eachfocus in situations of high DNA
damagelevels.This isthemain reasonwhyc-H2AXand not53BP1
was chosen to generate dose calibration curves and subsequent dose
estimates in this study. However, it is still advantageous to co-stain
with both to reduce the possibility of scoring fluorescent antibody
aggregates (visible in only one fluorescent channel but not the other)
as foci.
The kinetics of c-H2AX foci and intensity and 53BP1 foci loss
over 96 hours were similar for all investigated doses. This suggests
that DSBs are repaired independently of each other, highlighted
by the similar half-lives observed between 1 and 4 Gy for c-H2AX
loss. Bi-exponential loss of c-H2AX and 53BP1 confirms the
concept that DSBs are repaired by a ‘fast’ and a ‘slow’ pathway
[25], the majority being repaired by the fast pathway within
4 hours of their formation (Fig. 1C).
c-H2AX dose calibration curves based on a single donor not
only accurately estimated doses for that donor, but also for many
others, suggesting low intra- and inter-donor variations in c-
H2AX induction and loss, one of the main strengths of cytogenetic
biodosimetry [3]. For microscopy and cytometry, 0.5 and 4 Gy
(non-lethal and potentially lethal doses respectively) could be
distinguished, and in no case would an incorrect classification have
been made. The c-H2AX calibration curve assumes a background
level of zero foci per cell. All the donors included in this study had
spontaneous foci levels of ,0.2 per cell; accordingly at 24 hours
post exposure a level of 0.2 foci per cell would give a dose estimate
of ,100 mGy. It should be noted that background levels of
spontaneous foci observed here and in published in/ex vivo studies
using peripheral blood lymphocytes [8,11,12] or other primary
human quiescent cells [26] are lower than those reported for
established cell lines, especially those derived from tumours (e.g.
[27]). This may be because peripheral blood lymphocytes are
always in the G0 phase of the cell cycle, so foci formation due to
replication stress, seen in rapidly dividing cell lines, will not
contribute to background levels. A minimum detectable dose for
whole body exposures for both microscopy and cytometry was
generated assuming a background mean foci/intensity per cell was
set at $0.2/6 respectively. The significant divide in the minimum
detectable dose between c-H2AX microscopy and flow cytometry
is highlighted in Figure 5.
Figure 3. c-H2AX foci analysis of a mixture of irradiated and unirradiated lymphocytes. (A) c-H2AX foci distribution at 24 hours after
exposure of 100% of the cells to 0.5 Gy or 10% of the cells to 4 Gy; mean foci per cell were 0.975 and 0.905, respectively. Note the logarithmic y-axis
scale. (B) Mean c-H2AX foci per cell as a function of the irradiated fraction. Linear regressions were fitted to all data points. (C) Equivalent whole body
dose estimates based on mean foci counts from Figure 3B and foci calibration curve presented in Figure 1E. (D) Poisson S values calculated for c-
H2AX foci distributions in partially irradiated lymphocytes. Dashed lines mark the significance thresholds of 21.96 and 1.96. (E) Estimated versus
actual irradiated fraction for the different simulated partial body exposures. Estimated fraction was calculated using the contaminated Poisson
method. The line indicates a one-to-one correlation. Values have been corrected for background. (F) Dose estimates to the irradiated fraction.
doi:10.1371/journal.pone.0025113.g003
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for DNA DSBs and the loss of a foci represents the repair of DSB.
The kinetics of foci loss over time presented here, however, deviate
somewhat from the reported kinetics of DSB repair in cell lines
analysed by pulsed-field gel electrophoresis (PFGE) [25]. The
slower repair times seen with foci scoring may result from some
DSBs (or heat labile sites that were recorded as DSBs in previous
studies [28]) being repaired within minutes of their formation such
that no visible foci can form.
In the frequent cases of partial body exposures, whole body dose
estimates will not only underestimate the peak dose delivered to
part of the body but will potentially result in the incorrect
treatment of a patient. Doses of 4 Gy or more will severely damage
the bone marrow and may thus necessitate bone marrow
transplantation; however if a small fraction of the bone marrow
has been spared from the exposure then this risky procedure may
not be required with treatment instead focusing on stimulating the
surviving haemopoietic cells to replenish those lost [29]. Highly
localised exposures to large doses, on the other hand, may result in
severe tissue damage which could potentially be prevented or
reduced by early clinical intervention [2]. Dispersion analysis of c-
H2AX foci and intensity in partially irradiated lymphocytes not
only detected partial body exposure but also provided an estimate
of the size of the irradiated fraction. Even in cases where mean foci
Figure 4. Flow cytometric c-H2AX intensity analysis of a mixture of 4 Gy-irradiated and unirradiated lymphocytes. (A) c-H2AX
intensity histograms for different irradiated fractions at 1 hour post exposure. (B) Equivalent whole body dose estimates based on mean intensity
measurements from Figure 4A and the intensity calibration function presented in Figure 2C. (C) Poisson U values calculated for c-H2AX intensity
distributions in partially irradiated lymphocytes. (D) Estimated versus actual irradiated fraction for the different partial exposures. Estimated fraction
was calculated using the contaminated Poisson method. The line indicates a one-to-one correlation. (E) Dose estimates to the irradiated fraction.
doi:10.1371/journal.pone.0025113.g004
Figure 5. Minimum detectable dose for microscopic vs. flow
cytometric c-H2AX biodosimetry over 96 hours post exposure.
doi:10.1371/journal.pone.0025113.g005
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delivered to 10% of the lymphocytes, analysed 24 hours post
exposure, the Poisson s value increased above 1.96, indicating an
over-dispersion of foci (20.75 vs 3.23). Separate analysis of only
the irradiated cells resulted in a significant increase in foci numbers
versus background and enabled estimation of the partial body dose
(Fig. 3). Dose estimates for the irradiated fraction, based only on
cells containing foci, were largely accurate and more so than for
flow cytometry measurements. The good correlation of estimated
irradiated fractions and doses with actual values also suggests that
few, if any, foci were induced through bystander-type effects in
unirradiated cells under ex vivo conditions [30].
For protracted exposures, dose estimates made within a few
hours after the end of the exposure would be highly inaccurate due
to the rapid rate at which the majority of c-H2AX foci are lost.
Dose estimates made over 8 hours post exposure however would
have greater accuracy as only c-H2AX foci lost through slow
repair kinetics are left at this time where the difference between a
protracted and acute exposure would be less evident. For
protracted exposures lasting over 24 hours c-H2AX foci scoring
would not be an appropriate method for dose estimation. As
different types of ionising radiation may have different foci yields
and repair kinetics (e.g. [31]), individual c-H2AX calibration
curves have to be established, similar to the situation for the
dicentric assay for biological dosimetry [3]. More work is needed
in this area to fully establish the impact of radiation quality on c-
H2AX foci induction and their repair.
For rapid biodosimetry in a triage scenario following unplanned
radiation exposure, microscopic scoring of c-H2AX and 53BP1
foci offers great potential. Its satisfactory sensitivity up to several
days post exposure, ability to determine critical partial body
exposure and low inter and intra-variation in donors clearly
outweigh any benefits that flow cytometry offers in terms of
automation and throughput. c-H2AX calibration data from a
much larger cohort of subjects would allow for 95% confidence
limits to be refined to improve current biological and statistical
uncertainties. Induction of c-H2AX foci in X-irradiated lympho-
cytes is very similar in both in vivo and ex vivo settings [8,13], while
persistent c-H2AX foci have been observed up to 9 days post
exposure to X-rays in non-human primate models [12]. It also
remains to be seen to which extent variations in c-H2AX levels
may be indicative of individual radiosensitivity. Whilst such a
correlation has been reported for cases with severe genetic DNA
repair deficiencies such as Ataxia Telangiectasia [32] or Ligase IV
Syndrome [6] as well as in some non-syndromic radiotherapy
patients [33], others have reported a lack of correlation [34,35].
Further studies of c-H2AX and 53BP1 in clinical and non-clinical
settings may further improve current uncertainties in dose
estimation and clarify their association with individual clinical
outcome.
Materials and Methods
Blood collection and irradiation
After obtaining ethical approval from the Berkshire research
ethics committee (Ref 09/H0505/87) and informed consent from
donors, peripheral blood from 21 healthy donors (no previous
medical radiation exposures, aged 24–65, 11 males and 10
females) was collected into EDTA vacutainer tubes. Blood from
the same donor were used for all experiments except Figures 1F
and 2D. Blood was mixed with an equal volume of PBS and
lymphocytes were isolated using Histopaque-1077 solution (Sigma-
Aldrich) and resuspended in minimum essential medium (supple-
mented with 10% foetal calf serum, 1% L-glutamine and 1%
penicillin/streptomycin) at 37uC. Cells were then irradiated with
different doses of Cu/Al-filtered 250 kVp X-rays at 1.7 Gy/min
and mixed with unirradiated lymphocytes to contain 0, 10, 50, 90
and 100% irradiated cells. Cells were incubated at 37uC, 5% CO2
in a humidified atmosphere for up to 4 days.
Fixation, staining and scoring of c-H2AX and 53BP1 foci
Cells were spotted onto glass Superfrost Plus slides (VWR
international) at a concentration of ,1610
6 cells/ml, fixed using
2% formaldehyde/PBS for 10 minutes, washed in PBS, permea-
bilised using 0.5% (v/v) Triton-X/PBS for 10 minutes then
washed in PBS. Blocking was achieved using 1% (w/v) bovine
serum albumin (BSA) in PBS for 30 minutes. Cells were then
incubated with a combination of 1:500 mouse monoclonal anti-c-
H2AX antibody (Abcam) and 1:400 rabbit polyclonal anti-53BP1
antibody (Bethyl Laboratories) in 1% BSA/PBS for 1 hour at
room temperature. Cells were then washed in 1% BSA/PBS,
incubated in 1:200 anti-mouse AlexaFluor 488 conjugated
antibody (Invitrogen), 1:200 anti-rabbit tetramethyl rodamine
isoiocyanate (TRITC) conjugated antibody (Jackson ImmunoR-
esearch) and 200 ng/ml 49,6-diamidino-2-phenylindole (DAPI) in
1% BSA/PBS for 1 hour at room temperature, washed in PBS,
dried, mounted with a cover slip using Vectashield (Vector
Laboratories) and sealed using nail polish. c-H2AX and 53BP1
foci were scored by eye with a Nikon Eclipse TE200 epifluores-
cence microscope using a 6100 objective with 1.3NA. Fifty cells
were scored for uniformly irradiated samples and two hundred for
partially irradiated samples.
Fixation, staining and measurements of c-H2AX intensity
Cells analysed using flow cytometry for c-H2AX were prepared
using the same protocol as those for microscopy except that all
steps were performed in centrifuge tubes in suspension, not on
slides. Propidium iodide was used instead of DAPI for DNA
staining, and only c-H2AX staining was used. Fluorescence
intensities were quantified using a FACSCalibur flow cytometer
(Becton Dickinson). Individual G0 lymphocytes with intact nuclei
were selected and analysed based on their DNA signal (propidium
iodide intensity), forward scatter and side scatter with a minimum
of 5000 cells measured for each experiment. As 53BP1 relocalises
to DSBs after exposure to ionising radiation (total protein levels do
not increase), detection using flow cytometry is not applicable.
Calculation of over-dispersion and irradiated fraction size
To test for over-dispersion and deviation from a Poisson
distribution in c-H2AX/53BP1 foci numbers in partially irradi-
ated lymphocytes, the zero contaminated Poisson test or s test was
used. The s test takes into account the large number of cells with
zero foci that will appear in partially irradiated lymphocytes [36].
For c-H2AX intensity measurements, the u test was used, which
measures the deviation of the signal distribution in the sample
from a Poisson distribution [37]. The u test was chosen instead of
the s test as even unirradiated cells have a small degree of
fluorescence. For both the s and u test, values below 21.96
indicate under-dispersion, between 21.96 and 1.96 a Poisson
distribution and over 1.96 an over-dispersion. Dolphin’s contam-
inated Poisson model was then used to calculate an estimate of the
fraction of lymphocytes irradiated, and these estimates were
compared with the actual irradiated fraction size [38].
Statistical Analysis
All error bars represent the standard deviation of two
independent experiments. For the t-test, foci and intensity levels
Dose Estimates Based on Gamma-H2AX
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from the same donor. Pearson’s chi-square test was used to
determine the goodness of fit.
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